Victory Capital Management
CATX icon

Victory Capital Management’s Perspective Therapeutics CATX Stock Holding History

Victory Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1K Buy
+10,567
New +$44.6K ﹤0.01% 2320
2025
Q1 		– Sell
-49,420
Closed -$158K – 2481
2024
Q4 		$158K Sell
49,420
-1,040
-2% -$8.49K ﹤0.01% 2274
2024
Q3 		$674K Buy
50,460
+38,690
+329% +$515K ﹤0.01% 1928
2024
Q2 		$117K Buy
+11,770
New +$170K ﹤0.01% 2274
2023
Q1 		– Sell
-1,596
Closed -$3.94K – 2604
2022
Q4 		$3.94K Sell
1,596
-1
-0.1% -$3 ﹤0.01% 2574
2022
Q3 		$4K Sell
1,597
-398
-20% -$1.36K ﹤0.01% 2683
2022
Q2 		$6K Sell
1,995
-14
-0.7% -$43 ﹤0.01% 2673
2022
Q1 		$6K Sell
2,009
-55
-3% -$201 ﹤0.01% 2698
2021
Q4 		$8K Sell
2,064
-58
-3% -$309 ﹤0.01% 2736
2021
Q3 		$13K Sell
2,122
-107
-5% -$729 ﹤0.01% 2749
2021
Q2 		$18K Sell
2,229
-65
-3% -$569 ﹤0.01% 2711
2021
Q1 		$25K Buy
2,294
+833
+57% +$12.6K ﹤0.01% 2709
2020
Q4 		$7K Buy
1,461
+386
+36% +$1.71K ﹤0.01% 2523
2020
Q3 		$6K Sell
1,075
-62
-5% -$404 ﹤0.01% 2470
2020
Q2 		$6K Sell
1,137
-1,207
-51% -$7.76K ﹤0.01% 2484
2020
Q1 		$12K Buy
+2,344
New +$17.7K ﹤0.01% 3246
2019
Q4 		– Sell
-1,204
Closed -$4K – 2734
2019
Q3 		$4K Buy
+1,204
New +$4.36K ﹤0.01% 3495

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's CATX Position: Q1 2026 in Review

Victory Capital Management opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 10,567 shares worth $44.1K. The stake represents ﹤0.01% of the portfolio and ranks #2320 among its holdings. This is a return to the name: Victory Capital Management previously reported a position in CATX as recently as Q4 2024.

Victory Capital Management first reported a position in CATX in Q3 2019 and has held it in 17 quarters since. The position peaked at $674K in Q3 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Victory Capital Management held 10,567 shares of Perspective Therapeutics worth $44.1K as of Q1 2026.
  • Perspective Therapeutics was a new Victory Capital Management position in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2320 holding.
  • Victory Capital Management first reported a position in Perspective Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • Victory Capital Management's Perspective Therapeutics position peaked at $674K in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.